gliclazide has been researched along with mangiferin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Malarvizhi, R; Mani, S; Nithya, P; Sekar, V; Vasanthi, HR | 1 |
| Barathidasan, R; Malarvizhi, R; Mani, S; Sekar, V; Vasanthi, HR | 1 |
2 other study(ies) available for gliclazide and mangiferin
| Article | Year |
|---|---|
Antidiabetic effect of mangiferin in combination with oral hypoglycemic agents metformin and gliclazide.
Topics: Administration, Oral; Animals; Diabetes Mellitus, Experimental; Drug Therapy, Combination; Enzymes; Gene Expression Regulation; Gliclazide; Hep G2 Cells; Humans; Hypoglycemic Agents; Insulin; Liver; Male; Metformin; Rats, Sprague-Dawley; Xanthones | 2019 |
Positive interaction of mangiferin with selected oral hypoglycemic drugs: a therapeutic strategy to alleviate diabetic nephropathy in experimental rats.
Topics: Animals; Antioxidants; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Drug Therapy, Combination; Gliclazide; Hypoglycemic Agents; Kidney; Kidney Function Tests; Male; Metformin; NF-kappa B; Oxidative Stress; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Xanthones | 2020 |